Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v11-EN
Language French English
Date Updated 2025-02-19 2025-02-19
Drug Identification Number 02458969 02458969
Brand name PANTOPRAZOLE FOR INJECTION PANTOPRAZOLE FOR INJECTION
Common or Proper name PANTOPRAZOLE FOR INJECTION PANTOPRAZOLE FOR INJECTION
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients PANTOPRAZOLE PANTOPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 10Ml Vial X 10 10Ml Vial X 10
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2024-06-06 2024-06-06
Estimated end date Unknown Unknown
Actual end date 2025-02-18 2025-02-18
Shortage status Resolved Resolved
Tier 3 Status Yes Yes
Company comments PANTOPRAZOLE FOR INJECTION is now available under Eugia Pharma label (DIN 02528835 ). PANTOPRAZOLE FOR INJECTION is now available under Eugia Pharma label (DIN 02528835 ).
Health Canada comments